samedan logo
 
 
 
spacer
home > pmps > summer 2018 > bearing life
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bearing Life

The market for bearings is growing, particularly for use in high-accuracy machinery in the pharmaceutical industry. This article explains the impact of radial and thrust forces and what engineers can do to match the right bearing to the load.

The global market for bearings was valued at US $81.6 billion in 2015 and is expected to grow to $172.2 billion by 2025, according to a report by Grand View Research (1). One of the fastest growing subsectors is the miniature ball bearing market − featuring small and miniature bearings with an interior diameter of 9mm or smaller − which is forecast to reach a market value of $2.3 billion by 2026 and expected to increase at a compound annual growth rate of 9% in terms of revenue from 2018-2026 (2).

One key trend is a demand for bearings that can handle the unique challenges posed by chemical and pharma manufacturing and packaging, while still delivering high levels of accuracy, smoothness, and equipment life.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Chris Johnson is Managing Director at SMB Bearings. The Oxfordshire-based company specialises in the supply and relubrication of miniature bearings. Chris has managed operations at the company for over eight years and has made a conscious effort to make it a specialist in miniature, corrosion-resistant, and thin-section bearings. 
spacer
Chris Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

BioT ULT Transporter

BioCision

The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature­-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies. This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement